Cargando…

Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends

OBJECTIVE: To elucidate the outcomes of surgical lung biopsies (SLBs) performed for indications other than interstitial lung disease (ILD) and stratify outcomes according to procedural approach (open vs thoracoscopic). PATIENTS AND METHODS: Using the Nationwide Inpatient Sample database (January 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Samhouri, Bilal F., Kanj, Amjad N., Chehab, Omar, Ryu, Jay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043564/
https://www.ncbi.nlm.nih.gov/pubmed/35498392
http://dx.doi.org/10.1016/j.mayocpiqo.2021.12.003
_version_ 1784694909470507008
author Samhouri, Bilal F.
Kanj, Amjad N.
Chehab, Omar
Ryu, Jay H.
author_facet Samhouri, Bilal F.
Kanj, Amjad N.
Chehab, Omar
Ryu, Jay H.
author_sort Samhouri, Bilal F.
collection PubMed
description OBJECTIVE: To elucidate the outcomes of surgical lung biopsies (SLBs) performed for indications other than interstitial lung disease (ILD) and stratify outcomes according to procedural approach (open vs thoracoscopic). PATIENTS AND METHODS: Using the Nationwide Inpatient Sample database (January 1, 2008, through December 31, 2014), we identified elective hospitalizations with International Classification of Diseases, Ninth Revision, Clinical Modification codes for open (33.28) and thoracoscopic (33.20) SLB. We stratified cases by the presence/absence of ILD. Our primary outcome was in-hospital mortality. RESULTS: There were 47,469 hospitalizations for elective SLB (26,540 [55.9%] thoracoscopic) during the study period; 23,930 patients (50.5%) were women, 17,019 (35.9%) had ILD, and the mean ± SD age was 62.6±13.0 years. Over the study period, thoracoscopic increasingly replaced open SLB, and in-hospital mortality declined (3.5% [308 of 8678] in 2008 vs 2.5% [130 of 5215] in 2014; P<.001). Mortality following thoracoscopic SLB was 2.1% (550 of 26,519; 1.9% [214 of 11,513] in ILD and 2.2% [336 of 15,006] in non-ILD), and mean ± SD length of stay was 5.1±6.9 days. Open SLBs had worse outcomes; mortality was 3.7% (782 of 20,914; 3.9% [214 of 5487] in ILD and 3.7% [568 of 15,427] in non-ILD), and mean ± SD length of stay was 8.2±12 days. On multivariable analysis, male sex, advanced age, ILD, and higher comorbidity index correlated with higher mortality. Conversely, lower mortality was observed among individuals with obesity (odds ratio, 0.73; 95% CI, 0.60-0.88) and those who had their thoracoscopic SLBs performed at high-volume centers (top quartile) (odds ratio, 0.73; 95% CI, 0.57-0.94). CONCLUSION: Surgical lung biopsy is more often performed for non-ILD indications. Interstitial lung disease was an independent predictor of poor outcomes, but the unadjusted outcomes were worse in the non-ILD cohort due to differences in patient characteristics. Thoracoscopic SLBs performed at high-volume centers had superior outcomes.
format Online
Article
Text
id pubmed-9043564
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90435642022-04-28 Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends Samhouri, Bilal F. Kanj, Amjad N. Chehab, Omar Ryu, Jay H. Mayo Clin Proc Innov Qual Outcomes Original Article OBJECTIVE: To elucidate the outcomes of surgical lung biopsies (SLBs) performed for indications other than interstitial lung disease (ILD) and stratify outcomes according to procedural approach (open vs thoracoscopic). PATIENTS AND METHODS: Using the Nationwide Inpatient Sample database (January 1, 2008, through December 31, 2014), we identified elective hospitalizations with International Classification of Diseases, Ninth Revision, Clinical Modification codes for open (33.28) and thoracoscopic (33.20) SLB. We stratified cases by the presence/absence of ILD. Our primary outcome was in-hospital mortality. RESULTS: There were 47,469 hospitalizations for elective SLB (26,540 [55.9%] thoracoscopic) during the study period; 23,930 patients (50.5%) were women, 17,019 (35.9%) had ILD, and the mean ± SD age was 62.6±13.0 years. Over the study period, thoracoscopic increasingly replaced open SLB, and in-hospital mortality declined (3.5% [308 of 8678] in 2008 vs 2.5% [130 of 5215] in 2014; P<.001). Mortality following thoracoscopic SLB was 2.1% (550 of 26,519; 1.9% [214 of 11,513] in ILD and 2.2% [336 of 15,006] in non-ILD), and mean ± SD length of stay was 5.1±6.9 days. Open SLBs had worse outcomes; mortality was 3.7% (782 of 20,914; 3.9% [214 of 5487] in ILD and 3.7% [568 of 15,427] in non-ILD), and mean ± SD length of stay was 8.2±12 days. On multivariable analysis, male sex, advanced age, ILD, and higher comorbidity index correlated with higher mortality. Conversely, lower mortality was observed among individuals with obesity (odds ratio, 0.73; 95% CI, 0.60-0.88) and those who had their thoracoscopic SLBs performed at high-volume centers (top quartile) (odds ratio, 0.73; 95% CI, 0.57-0.94). CONCLUSION: Surgical lung biopsy is more often performed for non-ILD indications. Interstitial lung disease was an independent predictor of poor outcomes, but the unadjusted outcomes were worse in the non-ILD cohort due to differences in patient characteristics. Thoracoscopic SLBs performed at high-volume centers had superior outcomes. Elsevier 2022-02-04 /pmc/articles/PMC9043564/ /pubmed/35498392 http://dx.doi.org/10.1016/j.mayocpiqo.2021.12.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Samhouri, Bilal F.
Kanj, Amjad N.
Chehab, Omar
Ryu, Jay H.
Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title_full Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title_fullStr Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title_full_unstemmed Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title_short Outcomes for Elective Open and Thoracoscopic Surgical Lung Biopsies in the United States and Temporal Trends
title_sort outcomes for elective open and thoracoscopic surgical lung biopsies in the united states and temporal trends
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043564/
https://www.ncbi.nlm.nih.gov/pubmed/35498392
http://dx.doi.org/10.1016/j.mayocpiqo.2021.12.003
work_keys_str_mv AT samhouribilalf outcomesforelectiveopenandthoracoscopicsurgicallungbiopsiesintheunitedstatesandtemporaltrends
AT kanjamjadn outcomesforelectiveopenandthoracoscopicsurgicallungbiopsiesintheunitedstatesandtemporaltrends
AT chehabomar outcomesforelectiveopenandthoracoscopicsurgicallungbiopsiesintheunitedstatesandtemporaltrends
AT ryujayh outcomesforelectiveopenandthoracoscopicsurgicallungbiopsiesintheunitedstatesandtemporaltrends